Feedback / Questions
laflunimus (AP-325) - Algiax
https://www.businesswire.com/news/home/20250203838341/en/Algiax-Announces-Positive-Data-from-Phase-2a-Proof-of-Concept-Study-Evaluating-AP-325-in-Patients-with-Neuropathic-Pain
Feb 4, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next